Treats nosocomial pneumonia due to methicillin-susceptible Staphylococcus aureus…. ANDA 201043, held by Aurobindo Pharma Ltd. Levofloxacin.
As of Nov 16, 2026, ANDA 201043 (Levofloxacin), held by Aurobindo Pharma Ltd, was first approved by FDA on Jun 20, 2011, with 16 approved supplements and 0 published complete response letters.
Levofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1, 12.4 ). Pneumonia: Nosocomial and Community Acquired ( 1.2, 1.3 ) Skin and Skin Structure Infections (SSSI): Complicated and Uncomplicated Chronic bacterial prostatitis Inhalational Anthrax, Post-Exposure in adult and pediatric patients Plague in adult and pediatric patients Urinary Tract Infections (UTI): Complicated ( 1.9, 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 20, 2011 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Rx |
| Sep 20, 2024 | Supplement 34Labeling · Standard review | Approved | None posted |
| Oct 19, 2020 | Supplement 28Labeling · Standard review | Approved | None posted |
| Oct 19, 2020 | Supplement 22Labeling · Standard review | Approved | None posted |
| Oct 19, 2020 | Supplement 21Labeling · Standard review | Approved | None posted |
| May 6, 2019 | Supplement 18Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 16Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 14Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 12Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Oct 8, 2015 | Supplement 9Labeling · Standard review | Approved | None posted |
| Oct 8, 2015 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jul 25, 2012 | Supplement 5Labeling · Standard review | Approved | None posted |
| Mar 29, 2012 | Supplement 4REMS | Approved | None posted |
| Jan 19, 2012 | Supplement 2Labeling | Approved | None posted |
| Oct 20, 2011 | Supplement 1Labeling | Approved | None posted |
| Jun 20, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters